Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 CAD | +1.53% | +0.76% | +1.53% |
12:00am | Itafos Inc. Announces Results of Updated Itafos Conda Technical Report | CI |
Apr. 15 | RBC Capital Markets Gives Nutrien Outperform Rating, US$70 Price Target | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 104 | 69.86 | 36.34 | 220.2 | 199.1 | 188.3 |
Enterprise Value (EV) 1 | 256.1 | 263.5 | 283.7 | 442.4 | 299.9 | 261.1 |
P/E ratio | -0.89 x | -0.49 x | -0.57 x | 4.36 x | 1.76 x | 49.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.34 x | 0.21 x | 0.14 x | 0.53 x | 0.34 x | 0.4 x |
EV / Revenue | 0.85 x | 0.78 x | 1.09 x | 1.07 x | 0.51 x | 0.56 x |
EV / EBITDA | 8.29 x | -62 x | 29.4 x | 3.29 x | 1.37 x | 2.02 x |
EV / FCF | -1.84 x | 35.3 x | -17.7 x | 17.9 x | 2.65 x | 7.28 x |
FCF Yield | -54.2% | 2.83% | -5.66% | 5.58% | 37.7% | 13.7% |
Price to Book | 0.4 x | 0.67 x | 0.44 x | 1.65 x | 0.79 x | 0.73 x |
Nbr of stocks (in thousands) | 142,070 | 140,484 | 185,463 | 186,815 | 188,771 | 190,608 |
Reference price 2 | 0.7322 | 0.4973 | 0.1960 | 1.178 | 1.055 | 0.9881 |
Announcement Date | 4/4/19 | 3/27/20 | 3/25/21 | 3/24/22 | 3/23/23 | 3/21/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 302.2 | 339.4 | 260.2 | 413.2 | 593.3 | 465.5 |
EBITDA 1 | 30.91 | -4.247 | 9.659 | 134.3 | 219.6 | 129.2 |
EBIT 1 | -22.81 | -67.5 | -35.66 | 111 | 185.4 | 90.57 |
Operating Margin | -7.55% | -19.89% | -13.7% | 26.86% | 31.25% | 19.45% |
Earnings before Tax (EBT) 1 | -105.2 | -148.2 | -72.05 | 73.54 | 146.9 | 4.234 |
Net income 1 | -113.5 | -144.2 | -63.06 | 51.03 | 115.1 | 3.861 |
Net margin | -37.56% | -42.47% | -24.24% | 12.35% | 19.4% | 0.83% |
EPS 2 | -0.8200 | -1.024 | -0.3415 | 0.2700 | 0.6000 | 0.0200 |
Free Cash Flow 1 | -138.9 | 7.458 | -16.07 | 24.68 | 113.2 | 35.86 |
FCF margin | -45.97% | 2.2% | -6.18% | 5.97% | 19.08% | 7.7% |
FCF Conversion (EBITDA) | - | - | - | 18.37% | 51.54% | 27.77% |
FCF Conversion (Net income) | - | - | - | 48.37% | 98.33% | 928.86% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/4/19 | 3/27/20 | 3/25/21 | 3/24/22 | 3/23/23 | 3/21/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 129.7 | 146.4 | 195.1 | 197.7 | 203.6 | 185.7 | 159.9 | 156.1 | 152.9 | 161.4 |
EBITDA 1 | 51.84 | 60.06 | 78.62 | 81.11 | 67.34 | 68.83 | 57.43 | 53.39 | 27.12 | 39.93 |
EBIT | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
Net income 1 | 19.22 | 30.44 | 42.98 | 56.48 | 10.75 | 40.8 | 37.7 | 27.43 | 4.277 | -64.89 |
Net margin | 14.82% | 20.79% | 22.03% | 28.57% | 5.28% | 21.97% | 23.58% | 17.57% | 2.8% | -40.2% |
EPS 2 | 0.1007 | 0.1630 | 0.2214 | 0.2934 | 0.0532 | 0.2060 | 0.2005 | 0.1400 | 0.0200 | -0.3390 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/11/21 | 3/24/22 | 5/12/22 | 8/11/22 | 11/14/22 | 3/23/23 | 5/10/23 | 8/9/23 | 11/8/23 | 3/21/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 152 | 194 | 247 | 222 | 101 | 72.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.92 x | -45.59 x | 25.61 x | 1.654 x | 0.459 x | 0.5636 x |
Free Cash Flow 1 | -139 | 7.46 | -16.1 | 24.7 | 113 | 35.9 |
ROE (net income / shareholders' equity) | -35.8% | -69.6% | -55.5% | 47.4% | 59.2% | 1.21% |
ROA (Net income/ Total Assets) | -2.86% | -7.76% | -4.51% | 12.5% | 18.6% | 9.42% |
Assets 1 | 3,971 | 1,858 | 1,398 | 408.7 | 619.8 | 40.97 |
Book Value Per Share 2 | 1.850 | 0.7500 | 0.4400 | 0.7100 | 1.340 | 1.360 |
Cash Flow per Share 2 | 0.0700 | 0.1600 | 0.0500 | 0.1700 | 0.2300 | 0.1600 |
Capex 1 | 63.3 | 46.6 | 14 | 34.1 | 39 | 54.8 |
Capex / Sales | 20.96% | 13.71% | 5.37% | 8.25% | 6.57% | 11.76% |
Announcement Date | 4/4/19 | 3/27/20 | 3/25/21 | 3/24/22 | 3/23/23 | 3/21/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.53% | 186M | |
+1.67% | 15.17B | |
-14.18% | 15.06B | |
+6.58% | 12.61B | |
-13.63% | 9.92B | |
-11.85% | 7.34B | |
-.--% | 7.21B | |
-3.50% | 4.25B | |
-27.17% | 2.43B | |
+2.63% | 2.07B |
- Stock Market
- Equities
- IFOS Stock
- Financials Itafos Inc.